Cancer

apceth is the latest firm to form a CAR T-cell collab

German firm joins CAR-T party

By Fiona BARRY

German biopharma apceth has announced a CAR T-cell immunotherapy partnership with the University of Cologne.

Goodwin to manufacture ADC for Aspyrian

Goodwin to manufacture ADC for Aspyrian

By Zachary Brennan

Aspyrian Therapeutics has selected CDMO Goodwin Biotechnology to complete process development, scale-up, and cGMP manufacturing of their novel antibody drug conjugate (ADC).